공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

항생물질 : 기술과 세계 시장

Antibiotics: Technologies and Global Markets

리서치사 BCC Research
발행일 2020년 12월 상품 코드 980078
페이지 정보 영문 170 Pages
가격
US $ 5,500 ₩ 6,380,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 1회이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,600 ₩ 7,656,000 PDF (2-5 Users) help
동일 사업장 내 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄기능에 제약은 없으나 원칙적으로 허용된 인쇄횟수는 5회까지이며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,920 ₩ 9,187,000 PDF (Site License) help
동일 사업장 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 9,504 ₩ 11,025,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


항생물질 : 기술과 세계 시장 Antibiotics: Technologies and Global Markets
발행일 : 2020년 12월 페이지 정보 : 영문 170 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 항생물질 시장은 2020년 444억 달러에서 2025년까지 654억 달러에 달하고, 2020-2025년 CAGR로 8.1%의 성장이 예측됩니다.

세포벽 억제제 부문은 2020년 234억 달러에서 2025년까지 351억 달러에 달하고, 2020-2025년 CAGR로 8.4%의 성장이 예측됩니다.

단백질 억제제 부문은 2020년 136억 달러에서 2025년까지 202억 달러에 달하고, 2020-2025년 CAGR로 8.3%의 성장이 예측됩니다.

세계의 항생물질(Antibiotics) 시장에 대해 조사 분석했으며, 시장 개요, 시장 역학, 시장 내역, 주요 기업 등에 대한 체계적인 정보를 제공합니다.

목차

제1장 서론

제2장 요약과 하이라이트

제3장 시장 및 기술 배경

  • 항생물질 개요
  • 항생물질의 일반적인 부작용
  • 항생물질 분류
  • 세포벽 억제제
  • 단백질 억제제
  • DNA 억제제
  • 기타 항생물질 클래스
  • 그램 음성균과 그램 양성균 개요
  • 투여 경로
  • 항생물질 시장 동향
  • 새로운 항생물질 개발을 위한 자금
  • 소규모 제약 기업에 의한 항생물질 개발에 대한 주목 상승
  • 민관 파트너십 확대

제4장 시장 역학

  • 시장 성장 촉진요인
  • 항생물질에 견인된 세계의 의약품 시장 성장
  • 고령자 인구 증가와 감염률
  • 원내감염 유병률 증가
  • 질환과 그 항생물질에 관한 인식 향상
  • 시장 성장 억제요인
  • 항생물질 내성 감염증
  • 항생물질과 의약품 제네릭화
  • 연구개발(R&D) 투자 감소
  • 항생물질의 부작용
  • 시장 기회
  • 신흥 국가로의 시장 확대
  • 신규 항균제 개발

제5장 시장 내역 : 제품별

  • 세계의 항생물질 시장 : 제품별
  • 세포벽 억제제
  • 단백질 억제제
  • DNA 억제제
  • 기타

제6장 시장 내역 : 투여 경로별

  • 세계의 항생물질 시장 : 투여 경로별
  • 경구
  • 국소
  • 기타

제7장 시장 내역 : 지역별

  • 세계의 항생물질 시장 : 지역별
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제8장 제약 업계에 대한 COVID-19의 영향

  • 단기적인 영향
  • 수요 변화
  • 커뮤니케이션과 프로모션을 원격으로 이동
  • 연구개발 변경
  • 장기적인 영향
  • COVID와 관련되지 않은 의약품의 승인 지연
  • 제약 업계의 자급
  • 제약 업계의 성장이 둔화
  • 건강 관련 상품의 소비 동향 변화

제9장 임상 개발과 파이프라인 제품

  • 호흡기 감염증

제10장 밸류체인 분석

  • 서론
  • 중국이 미생물 위협의 중심으로

제11장 규제 시나리오

  • FDA·국제 규제
  • 최근의 규제 개혁
  • Ketek 사례 연구

제12장 경쟁 상황

  • 세계 기업의 시장 점유율 분석
  • 합병, 제휴, 파트너십, 인수

제13장 기업 개요

  • ABBOTT
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • MERCK & CO., INC.
  • MYLAN N.V.
  • PFIZER INC.
  • SANOFI

제14장 부록 : 약어

KSM 21.01.14

List of Tables

  • Summary Table A : Global Market for Antibiotics, by Product, Through 2025
  • Summary Table B : Global Market for Antibiotics, by Route of Administration, Through 2025
  • Table 1 : Major Differences Between Gram-positive and Gram-negative Organisms
  • Table 2 : Proportion of Resistant Strains, by WHO Region
  • Table 3 : Global Market for Antibiotics, by Product, Through 2025
  • Table 4 : Global Market for Cell Wall Inhibitors, by Region, Through 2025
  • Table 5 : Global Market for Protein Inhibitors, by Region, Through 2025
  • Table 6 : Global Market for DNA Inhibitors, by Region, Through 2025
  • Table 7 : Global Market for Other Types of Inhibitors, by Region, Through 2025
  • Table 8 : Global Market for Antibiotics, by Route of Administration, Through 2025
  • Table 9 : Global Market for Oral Antibiotics, by Region, Through 2025
  • Table 10 : Global Market for Topical Antibiotics, by Region, Through 2025
  • Table 11 : Global Market for Other Routes of Administration of Antibiotics, by Region, Through 2025
  • Table 12 : Global Market for Antibiotics, by Region, Through 2025
  • Table 13 : North American Market for Antibiotics, by Product, Through 2025
  • Table 14 : North American Market for Antibiotics, by Route of Administration, Through 2025
  • Table 15 : North American Market for Antibiotics, by Country, Through 2025
  • Table 16 : European Market for Antibiotics, by Product, Through 2025
  • Table 17 : European Market for Antibiotics, by Route of Administration, Through 2025
  • Table 18 : European Market for Antibiotics, by Country, Through 2025
  • Table 19 : Asia-Pacific Market for Antibiotics, by Product, Through 2025
  • Table 20 : Asia-Pacific Market for Antibiotics, by Route of Administration, Through 2025
  • Table 21 : Asia-Pacific Market for Antibiotics, by Country, Through 2025
  • Table 22 : Latin American Market for Antibiotics, by Product, Through 2025
  • Table 23 : Latin American Market for Antibiotics, by Route of Administration, Through 2025
  • Table 24 : Latin American Market for Antibiotics, by Country, Through 2025
  • Table 25 : Middle Eastern and African Market for Antibiotics, by Product, Through 2025
  • Table 26 : Middle Eastern and African Market for Antibiotics, by Route of Administration, Through 2025
  • Table 27 : Middle Eastern and African Market for Antibiotics, by Country, Through 2025
  • Table 28 : Antibiotics and Combinations in Global Clinical Development and the Pipeline
  • Table 29 : FDA-Approved Antibacterial Drugs, 2018
  • Table 30 : FDA-Approved Antibacterial Drugs, 2019
  • Table 31 : Abbott: Antibiotics Product Portfolio
  • Table 32 : F. Hoffmann-La Roche AG: Antibiotics Product Portfolio
  • Table 33 : GlaxoSmithKline Plc: Antibiotics Product Portfolio
  • Table 34 : Johnson & Johnson: Antibiotics Product Portfolio
  • Table 35 : Merck & Co., Inc.: Antibiotics Product Portfolio
  • Table 36 : Merck & Co., Inc.: Antibiotic Drugs Overview
  • Table 37 : Mylan N.V.: Antibiotics Product Portfolio
  • Table 38 : Pfizer Inc.: Antibiotics Product Portfolio
  • Table 39 : Pfizer Inc.: Antibiotic Drugs Overview
  • Table 40 : Sanofi: Antibiotics Product Portfolio
  • Table 41 : Sanofi S.A.: Antibiotic Drugs Overview
  • Table 42 : Acronyms Used in this Report

List of Figures

  • Summary Figure A : Global Market Shares of Antibiotics, by Product, 2019
  • Summary Figure B : Global Market Shares of Antibiotics, by Route of Administration, 2019
  • Figure 1 : Share of API Manufacturing Facilities for All Drugs, by Country/Region, August 2019
  • Figure 2 : Share of Population Aged 65 Years or Over, by Region, 2019
  • Figure 3 : Forecasted Share of Population Aged 65 Years or Over, by Region, 2050
  • Figure 4 : Increase in Aging Population, 2011 and 2050
  • Figure 5 : Distribution of Population with HAIS in the U.S., 2014
  • Figure 6 : Major Socioeconomic and Political Factors Contributing to Antibiotic Resistance
  • Figure 7 : Global Market Shares of Antibiotics, by Product, 2019
  • Figure 8 : Global Market for Cell Wall Inhibitors, 2018-2025
  • Figure 9 : Global Market Shares of Antibiotics, by Cell Wall Inhibitor, 2019
  • Figure 10 : Global Market for Cell Wall Inhibitors, by Region, 2018-2025
  • Figure 11 : Global Market for Protein Inhibitors, 2018-2025
  • Figure 12 : Global Market Shares of Antibiotics, by Protein Inhibitor, 2019
  • Figure 13 : Global Market for Protein Inhibitors, by Region, 2018-2025
  • Figure 14 : Global Market for DNA Inhibitors, 2018-2025
  • Figure 15 : Global Market Shares of Antibiotics, by DNA Inhibitor, 2019
  • Figure 16 : Global Market for DNA Inhibitors, by Region, 2018-2025
  • Figure 17 : Global Market for Other Types of Inhibitors, 2018-2025
  • Figure 18 : Global Market for Other Types of Inhibitors, by Region, 2018-2025
  • Figure 19 : Global Market Shares of Antibiotics, by Route of Administration, 2019
  • Figure 20 : Global Market for Oral Antibiotics, 2018-2025
  • Figure 21 : Global Market for Oral Antibiotics, by Region, 2018-2025
  • Figure 22 : Global Market for Topical Antibiotics, 2018-2025
  • Figure 23 : Global Market for Topical Antibiotics, by Region, 2018-2025
  • Figure 24 : Global Market for Other Routes of Administration of Antibiotics, 2018-2025
  • Figure 25 : Global Market for Other Routes of Administration of Antibiotics, by Region, 2018-2025
  • Figure 26 : Global Market Shares of Antibiotics, by Region, 2019
  • Figure 27 : North American Market Shares of Antibiotics, by Product, 2019
  • Figure 28 : North American Market Shares of Antibiotics, by Cell Wall Inhibitor, 2019
  • Figure 29 : North American Market Shares of Antibiotics, by Protein Inhibitor, 2019
  • Figure 30 : North American Market Shares of Antibiotics, by DNA Inhibitor, 2019
  • Figure 31 : North American Market Shares of Antibiotics, by Route of Administration, 2019
  • Figure 32 : North American Market Shares of Antibiotics, by Country, 2019
  • Figure 33 : U.S. Market for Antibiotics, 2018-2025
  • Figure 34 : Canadian Market for Antibiotics, 2018-2025
  • Figure 35 : Mexican Market for Antibiotics, 2018-2025
  • Figure 36 : European Market Shares of Antibiotics, by Product, 2019
  • Figure 37 : European Market Shares of Antibiotics, by Cell Wall Inhibitor, 2019
  • Figure 38 : European Market Shares of Antibiotics, by Protein Inhibitor, 2019
  • Figure 39 : European Market Shares of Antibiotics, by DNA Inhibitor, 2019
  • Figure 40 : European Market Shares of Antibiotics, by Route of Administration, 2019
  • Figure 41 : European Market Shares of Antibiotics, by Country, 2019
  • Figure 42 : German Market for Antibiotics, 2018-2025
  • Figure 43 : French Market for Antibiotics, 2018-2025
  • Figure 44 : U.K. Market for Antibiotics, 2018-2025
  • Figure 45 : Italian Market for Antibiotics, 2018-2025
  • Figure 46 : Spanish Market for Antibiotics, 2018-2025
  • Figure 47 : Rest of the European Market for Antibiotics, 2018-2025
  • Figure 48 : Asia-Pacific Market Shares of Antibiotics, by Product, 2019
  • Figure 49 : Asia-Pacific Market Shares of Antibiotics, by Cell Wall Inhibitor, 2019
  • Figure 50 : Asia-Pacific Market Shares of Antibiotics, by Protein Inhibitor, 2019
  • Figure 51 : Asia-Pacific Market Shares of Antibiotics, by DNA Inhibitor, 2019
  • Figure 52 : Asia-Pacific Market Shares of Antibiotics, by Route of Administration, 2019
  • Figure 53 : Asia-Pacific Market Shares of Antibiotics, by Country, 2019
  • Figure 54 : Japanese Market for Antibiotics, 2018-2025
  • Figure 55 : Chinese Market for Antibiotics, 2018-2025
  • Figure 56 : Indian Market for Antibiotics, 2018-2025
  • Figure 57 : Australia and New Zealand Market for Antibiotics, 2018-2025
  • Figure 58 : Rest of Asia-Pacific Market for Antibiotics, 2018-2025
  • Figure 59 : Latin American Market Shares of Antibiotics, by Product, 2019
  • Figure 60 : Latin American Market Shares of Antibiotics, by Cell Wall Inhibitor, 2019
  • Figure 61 : Latin American Market Shares of Antibiotics, by Protein Inhibitor, 2019
  • Figure 62 : Latin American Market Shares of Antibiotics, by DNA Inhibitor, 2019
  • Figure 63 : Latin American Market Shares of Antibiotics, by Route of Administration, 2019
  • Figure 64 : Latin American Market Shares of Antibiotics, by Country, 2019
  • Figure 65 : Brazilian Market for Antibiotics, 2018-2025
  • Figure 66 : Argentinian Market for Antibiotics, 2018-2025
  • Figure 67 : Rest of Latin American Market for Antibiotics, 2018-2025
  • Figure 68 : Middle Eastern and African Market Shares of Antibiotics, by Product, 2019
  • Figure 69 : Middle Eastern and African Market Shares of Antibiotics, by Cell Wall Inhibitor, 2019
  • Figure 70 : Middle Eastern and African Market Shares of Antibiotics, by Protein Inhibitor, 2019
  • Figure 71 : Middle Eastern and African Market Shares of Antibiotics, by DNA Inhibitor, 2019
  • Figure 72 : Middle Eastern and African Market Shares of Antibiotics, by Route of Administration, 2019
  • Figure 73 : Middle Eastern and African Market Shares of Antibiotics, by Country, 2019
  • Figure 74 : Market for Antibiotics in the GCC Countries, 2018-2025
  • Figure 75 : South African Market for Antibiotics, 2018-2025
  • Figure 76 : Rest of Middle Eastern and African Market for Antibiotics, 2018-2025
  • Figure 77 : Impact of COVID-19 on the Pharmaceutical Industry
  • Figure 78 : Global Market Shares of Antibiotics, by Manufacturer, 2019
  • Figure 79 : Abbott: Annual Revenue, 2016-2019
  • Figure 80 : Abbott: Revenue Shares, by Country/Region, 2019
  • Figure 81 : Abbott: Revenue Shares, by Business Unit, 2019
  • Figure 82 : F. Hoffmann-La Roche AG: Annual Revenue, 2016-2019
  • Figure 83 : F. Hoffmann-La Roche AG: Revenue Shares in Pharmaceutical Segment, by Country/Region, 2019
  • Figure 84 : F. Hoffmann-La Roche AG: Revenue Shares, by Business Segment, 2019
  • Figure 85 : GlaxoSmithKline Plc: Annual Revenue, 2016-2019
  • Figure 86 : GlaxoSmithKline Plc: Revenue Shares, by Pharmaceuticals, 2019
  • Figure 87 : Johnson & Johnson: Annual Revenue, 2016-2019
  • Figure 88 : Johnson & Johnson: Revenue Shares, by Region, 2019
  • Figure 89 : Johnson & Johnson: Revenue Shares, by Business Unit, 2019
  • Figure 90 : 90Merck & Co., Inc.: Annual Revenue, 2016-2019
  • Figure 91 : Merck & Co., Inc.: Revenue Shares, by Region, 2019
  • Figure 92 : Merck & Co., Inc.: Revenue Shares, by Business Unit, 2019
  • Figure 93 : Mylan N.V.: Annual Revenue, 2016-2019
  • Figure 94 : Mylan N.V.: Revenue Shares, by Region, 2019
  • Figure 95 : Mylan N.V.: Revenue Shares, by Business Unit, 2019
  • Figure 96 : Pfizer Inc.: Annual Revenue, 2016-2019
  • Figure 97 : Pfizer Inc.: Revenue Shares, by Country/Region, 2019
  • Figure 98 : Pfizer Inc.: Revenue Shares, by Business Segment, 2019
  • Figure 99 : Sanofi: Annual Revenue, 2016-2019
  • Figure 100 : Sanofi: Revenue Shares, by Region/Country, 2019
  • Figure 101 : Sanofi: Revenue Shares, by Business Segment, 2019

Highlights:

The global market for antibiotics should grow from $44.4 billion in 2020 to reach $65.4 billion by 2025 at a compound annual growth rate (CAGR) of 8.1% during the period of 2020-2025.

The global market for cell wall inhibitor antibiotic drugs segment should grow from $23.4 billion in 2020 to reach $35.1 billion by 2025 at a CAGR of 8.4% during the period of 2020-2025.

The global market for protein inhibitor antibiotic drugs segment should grow from $13.6 billion in 2020 to reach $20.2billion by 2025 at a CAGR of 8.3% during the period of 2020-2025.

Report Scope:

The report focuses on newer drugs and innovations in chemical compounds, vaccines and biologicals, recently launched or in development. Specifically excluded from the scope of research are vector or mosquito control approaches, strategies and products; drugs used for symptomatic treatment and not for the elimination of the virus from the host; and details on manufacturers and suppliers of non-branded generics. This report will also highlight the current and future market potentiality of antibiotics with detailed analysis of competitive environment between the companies. Drivers, restraints, opportunities, pricing analysis, impact of COVID-19, other infectious diseases and a regulatory scenario assessment will be covered in the current report. The report covers a market projection for 2025, and a market share for key players.

The report segments the market for antibiotics based on product type, route of administration, application and geography. Based on product type, the market is segmented into cell wall inhibitors, protein inhibitors, DNA inhibitors and other inhibitors (RNA, Mycolic Acid, Folic Acid). Based on route of administration, the market is segmented into oral and topical. The market is also presented based on application type, which is further segmented into human and veterinary.

By geography, the market has been segmented into the North America, Europe, Asia-Pacific, South America, and Middle East and Africa regions. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa will be covered in the regional segment. For market estimates, data will be provided for 2019 as the base year, with estimates for 2020 and forecast value for 2025.

Report Includes:

  • 28 data tables and 16 additional tables
  • Comprehensive overview of the global market for antibiotics within the pharmaceutical industry
  • Analyses of the global market trends, with data corresponding to market size for 2018-2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Latest information on market growth drivers and opportunities, industry supply chain structure, regulatory developments, technological advancements, and demographic shifts shaping the overall antibiotics marketplace
  • Evaluation of market growth during the forecast period, and deep dive of market share analysis data basis of product type, product, route of administration, end-user and geographical region
  • Country specific data and analysis for the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa
  • Impact of COVID-19 on the pharmaceutical market for antibiotics and an outlook of short-term vs. long-term impacts of COVID-19 pandemic
  • Identification of the companies best positioned to meet the global market demand for antibiotic drugs on the basis of their proprietary technologies, M&A deals, collaborations, JVs and other strategic alliances
  • Detailed company profiles of the major global corporations, including Abbott, F. Hoffmann-La Roche AG, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Pfizer and Sanofi

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Overview of Antibiotics
  • Common Side Effects of Antibiotics
  • Classification of Antibiotics
  • Cell Wall Inhibitors
  • Protein Inhibitors
  • DNA Inhibitors
  • Other Antibiotic Classes
  • Overview of Gram-negative and Gram-positive Bacteria
  • Route of Administration
  • Trends in the Market for Antibiotics
  • Funding for New Antibiotic Development
  • Increasing Focus on Antibiotic Drug Development by Smaller Pharmaceutical Firms
  • Growing Public-Private Partnerships

Chapter 4 Market Dynamics

  • Market Drivers
  • Growth of the Global Pharmaceutical Market Driven by Antibiotics
  • Rise in Geriatric Population and Infection Rate
  • Increasing Prevalence of Hospital-acquired Infections
  • Improved Awareness about Diseases and their Antibiotics
  • Market Restraints
  • Antibiotic-resistant Infections
  • Genericization of Antibiotics and Drugs
  • Declining Research and Development (R&D) Investment
  • Side Effects of Antibiotics
  • Market Opportunities
  • Market Expansion into Emerging Countries
  • Development of Novel Antibacterial Agents

Chapter 5 Market Breakdown by Product

  • Global Market for Antibiotics by Product
  • Cell Wall Inhibitors
  • Protein Inhibitors
  • DNA Inhibitors
  • Other Types of Inhibitors

Chapter 6 Market Breakdown by Route of Administration

  • Global Market for Antibiotics by Route of Administration
  • Oral Antibiotics
  • Topical Antibiotics
  • Other Routes of Administration

Chapter 7 Market Breakdown by Region

  • Global Market for Antibiotics by Region
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Chapter 8 Impact of COVID-19 on the Pharmaceutical Industry

  • Short-term Impact
  • Change in Demand
  • Shift of Communication and Promotions to Remote Interactions
  • Research and Development Changes
  • Long-term Impact
  • Delayed Approvals for Non-COVID-related Pharmaceutical Products
  • Self-sufficiency in Pharma Industry
  • Pharmaceutical Industry Growth Slow-Down
  • Changes in Consumption Trends in Health-related Products

Chapter 9 Clinical Developments and Pipeline Products

  • Respiratory Tract Infections

Chapter 10 Value Chain Analysis

  • Introduction
  • China is a Becoming a Center of Microbial Threats

Chapter 11 Regulatory Scenario

  • FDA and International Regulation
  • Recent Regulatory Reforms
  • Ketek Case Study

Chapter 12 Competitive Landscape

  • Global Company Market Share Analysis
  • Mergers, Collaborations, Partnerships and Acquisitions

Chapter 13 Company Profiles

  • ABBOTT
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • MERCK & CO., INC.
  • MYLAN N.V.
  • PFIZER INC.
  • SANOFI

Chapter 14 Appendix: Acronyms

Back to Top
전화 문의
F A Q